Accuray (ARAY) Gross Profit Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.55% |
| Dec 31, 2025 | -10.03% |
| Sep 30, 2025 | -5.59% |
| Jun 30, 2025 | 36.35% |
| Mar 31, 2025 | -4.17% |
| Dec 31, 2024 | 2.02% |
| Sep 30, 2024 | 0.91% |
| Jun 30, 2024 | -36.21% |
| Mar 31, 2024 | -6.40% |
| Dec 31, 2023 | -28.05% |
| Sep 30, 2023 | -40.60% |
| Jun 30, 2023 | -34.44% |
| Mar 31, 2023 | 1.33% |
| Dec 31, 2022 | 1.77% |
| Sep 30, 2022 | -37.21% |
| Jun 30, 2022 | -36.11% |
| Mar 31, 2022 | -0.36% |
| Dec 31, 2021 | 6.31% |
| Sep 30, 2021 | -39.21% |
| Jun 30, 2021 | -42.52% |
| Mar 31, 2021 | -2.53% |
| Dec 31, 2020 | -0.83% |
| Sep 30, 2020 | 0.87% |
| Jun 30, 2020 | -50.65% |
| Mar 31, 2020 | 0.24% |
| Dec 31, 2019 | -0.31% |
| Sep 30, 2019 | 3.45% |
| Jun 30, 2019 | 3.62% |
| Mar 31, 2019 | 0.38% |
| Dec 31, 2018 | 0.11% |
| Sep 30, 2018 | 7.42% |
| Jun 30, 2018 | 11.95% |
| Mar 31, 2018 | 12.57% |
| Dec 31, 2017 | 8.13% |
| Sep 30, 2017 | 9.99% |
| Jun 30, 2017 | 3.43% |
| Mar 31, 2017 | -0.38% |
| Dec 31, 2016 | -4.85% |
| Sep 30, 2016 | 5.11% |
| Jun 30, 2016 | 2.97% |
| Mar 31, 2016 | 10.47% |
| Dec 31, 2015 | 7.64% |
| Sep 30, 2015 | 13.20% |